The antiproliferative effects of melatonin on experimental pituitary and colonic tumors. Possible involvement of the putative nuclear binding site?
Pawlikowski
M
M
Institute of Endocrinology, Medical University of Lodz, Poland.
Kunert-Radek
J
J
Winczyk
K
K
Melen-Mucha
G
G
Gruszka
A
A
Karasek
M
M
D000818:Animals; D002455:Cell Division / Q000187:drug effects; D002467:Cell Nucleus / Q000378:metabolism; D003110:Colonic Neoplasms / Q000139:chemically induced / Q000188:drug therapy / Q000473:pathology* / Q000517:prevention & control; D004054:Diethylstilbestrol; D008297:Male; D008550:Melatonin / Q000627:therapeutic use*; D051379:Mice; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D010911:Pituitary Neoplasms / Q000139:chemically induced / Q000188:drug therapy / Q000473:pathology* / Q000517:prevention & control; D051381:Rats; D017208:Rats, Wistar; D011956:Receptors, Cell Surface / Q000502:physiology; D018160:Receptors, Cytoplasmic and Nuclear / Q000502:physiology; D044094:Receptors, Melatonin; D013844:Thiazoles / Q000627:therapeutic use; D013882:Thiosemicarbazones / Q000627:therapeutic use
D011956:Receptors, Cell Surface; D018160:Receptors, Cytoplasmic and Nuclear; D044094:Receptors, Melatonin; D013844:Thiazoles; D013882:Thiosemicarbazones; D004054:Diethylstilbestrol; C092451:CGP 52608; D008550:Melatonin